Third Rock Ventures forms REVOLUTION Medicines, raises $45 mln for its launch
Third Rock Ventures LLC has launched REVOLUTION Medicines, a developer of new therapies derived from natural products, with $45 million in Series a funding. Dr. Mark A. Goldsmith, a partner at Third Rock Ventures, is serving as founding president and CEO of REVOLUTION Medicines.
4 February 2015•5 mins read
